Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 13, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Surgery in Oligometastatic Pancreatic Cancer: Narrative Systematic Review.

Ulrich Ronellenfitsch1,2, Rosa Klotz2, Jörg Kleeff1

  • 1Department of Visceral, Vascular and Endocrine Surgery, Medical Faculty of the Martin-Luther-University Halle-Wittenberg and University Hospital Halle (Saale), 06120 Halle (Saale), Germany.

Cancers
|June 12, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical residents' career interests in transplantation surgery in Germany - a nationwide survey.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

The Influence of Vitamin C on Stromal and Epithelial Cells of the Pancreas in Malignant and Benign/Inflammatory Pancreatic Diseases: Protocol for a Scoping Review.

JMIR research protocols·2026
Same author

Microbiome Diversity in Pancreatic Surgery: Associations with Preoperative Stenting and Postoperative Outcomes.

Microorganisms·2026
Same author

A cost comparison between patients undergoing robotic colorectal surgery with and without a clinical pathway.

Cost effectiveness and resource allocation : C/E·2026
Same author

The effect of delays in cancer surgery due to the COVID-19 pandemic on cancer resectability and postoperative mortality in different tumor entities.

Discover oncology·2026
Same author

Optimal management of potentially curable esophageal squamous cell carcinoma: what are the pillars of therapy?

Journal of thoracic disease·2026

Surgery may benefit selected patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC). This approach, involving resection of primary tumors and metastases, shows promise for prolonged survival in carefully chosen cases.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, especially in metastatic stages.
  • Oligometastatic disease, with limited spread, suggests a potentially better prognosis.
  • This has led to reconsidering metastasis-directed therapies, including surgery, for select PDAC patients.

Purpose of the Study:

  • To review the current literature on surgical treatment for oligometastatic PDAC.
  • To evaluate the feasibility, safety, and outcomes of surgical resection in these patients.

Main Methods:

  • A selective literature review using PubMed was performed.
  • Studies reporting surgical treatment for synchronous or metachronous oligometastatic PDAC were included.
  • Outcomes after resection of primary and/or metastatic lesions were analyzed narratively.
Keywords:
metastasectomymultimodal therapyoligometastatispancreatic ductal adenocarcinomasurgical resection

More Related Videos

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
10:04

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video

Published on: June 6, 2020

Related Experiment Videos

Last Updated: Jun 13, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
10:04

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video

Published on: June 6, 2020

Main Results:

  • Retrospective studies indicate surgical resection of primary tumors and metastases may be safe and feasible in selected oligometastatic PDAC patients.
  • Favorable factors include chemotherapy response, low tumor markers, limited metastases, and complete resection.
  • Isolated pulmonary metastases are associated with particularly good outcomes, though evidence is limited by selection bias.

Conclusions:

  • Surgery may benefit highly selected patients with oligometastatic PDAC as part of a multimodal strategy.
  • Ongoing clinical trials are crucial to define surgery's definitive role.
  • Individualized treatment decisions via multidisciplinary tumor boards are recommended pending further evidence.